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  1 
Abstract 2 
Background: Self-management and self-efficacy for physical activity is not routinely 3 
considered in neurologic rehabilitation.  4 
Objective: We assessed feasibility and outcomes of a 14 week physical activity self-5 
management and coaching intervention compared with social contact in Huntington's disease 6 
(HD) to inform the design of a future full-scale trial.  7 
Design: Assessor blind, multi-site, randomized pilot feasibility trial. 8 
Setting: Participants were recruited and assessed at baseline, 16 weeks following 9 
randomisation, and then again at 26 weeks in HD specialist clinics with intervention delivery 10 
by trained coaches in the participants’ homes.  11 
Patients and Intervention: People with HD were allocated to the ENGAGE-HD physical 12 
activity coaching intervention or a social interaction intervention.  13 
Measurements: Eligibility, recruitment, retention and intervention adherence were 14 
determined at 16 weeks. Other outcomes of interest included measures of functional, home 15 
and community mobility, self-efficacy, physical activity and disease-specific measures of 16 
motor and cognition. Fidelity and costs for both the physical activity and social comparator 17 
interventions were established. 18 
Results: Forty % (n=46) of eligible patients were enrolled and 22 randomised to the physical 19 
intervention and 24 to social intervention. Retention rates in the physical intervention and 20 
social intervention were 77% and 92% respectively. Minimum adherence criteria were 21 
achieved by 82% of participants in the physical intervention and 100% in the social 22 
intervention. There was no indication of between group treatment effects on function, 23 
however increases in self-efficacy for exercise and self-reported levels of physical activity in 24 
the physical intervention lends support to our pre-defined intervention logic model.  25 
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Limitations: The use of self-report measures may have introduced bias.    1 
Conclusions: An HD physical activity self-management and coaching intervention is feasible 2 
and worthy of further investigation.   3 
 4 
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Huntington’s disease (HD) is a fatal, autosomal dominantly inherited neurodegenerative 2 
disorder with a prevalence of 6-13/100,000 1. Death usually occurs between 15 and 30 years 3 
after onset of symptoms prior to which the complex disease symptoms, including motor, 4 
cognitive and behavioral impairments, result in loss of functional independence and 5 
progressive escalation of healthcare costs2. The personal, social and economic consequences 6 
of HD are devastating.  7 
 Arguably in HD, to date, trials of exercise interventions have surpassed 8 
pharmacological interventions in achieving functional benefit3–6.  Indeed numerous studies 9 
suggest that lifestyle factors, including physical activity and specific motor training, may help 10 
to drive compensatory neural networks that may in turn compensate for the failing brain and 11 
change the course of the disease7,8. Such interventions implemented in long term, 12 
neurodegenerative diseases such as HD have the potential to maintain function and facilitate 13 
independent living in a cost effective manner and are critical secondary prevention strategies 14 
that should be a core component of contemporary neurologic physical therapy (PT) practice. 15 
However, long term self-management skills for physical activity are rarely considered in 16 
clinical trials and home-based therapies9.  17 
 In HD, the nature of the disease (motor and non-motor features) can negatively impact 18 
motivation to initiate and sustain participation in physical activity and exercise interventions. 19 
The associated cognitive and mood disorders such as apathy and decreased motivation can 20 
affect the willingness and the ability of individuals to engage in physical activity, structured 21 
exercise or in activities outside the home. There is little evidence for effectiveness of 22 
behavioral interventions to support longer term adherence in complicated chronic conditions 23 
including stroke10,11 and, to our knowledge, no disease-specific approaches that have been 24 
purposely developed for HD or other highly complex neurodegenerative conditions. This is a 25 
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critical area to address not only to achieve the potential functional benefits that can be 1 
conferred from regular physical activity12 but also to manage sedentary behaviors that place 2 
these individuals at increased risk of secondary health complications.  3 
 We aimed to assess feasibility and explore outcomes of the ENGAGE-HD physical 4 
activity self-management and coaching intervention through the conduct of a randomized, 5 
controlled, pilot feasibility trial to inform the design of a future full-scale trial13. In focussing 6 
on a self-management approach that encouraged autonomy and goal setting, we were also 7 
interested in understanding the relevant interactions between provider and participant. For 8 
this reason, we included a social contact comparator. We also conducted a detailed economic 9 
costing to inform our understanding of the cost-benefit relationship of a physical activity 10 
intervention in relatively-rare long term neurodegenerative diseases such as HD.   11 




Design overview 2 
This was a single blind, multi-site pilot feasibility trial (ISRCTN 65378754) reported in line 3 
with the CONSORT extension for randomised pilot studies 14.  Participants were assessed at 4 
baseline on enrolment into the trial. Following baseline assessment, participants were 5 
randomised to a physical activity or social interaction intervention.  A blinded assessor 6 
reassessed participants at 16 weeks following randomisation, and then again at 26 weeks. At 7 
the end of the study, all participants were offered a brief version of the alternative 8 
intervention with 1 home visit and 1 follow up phone call.  The schedule of enrolment, 9 
interventions, and assessments are shown in Table 1 below.  10 
<Table 1> 11 
Setting and Participants 12 
The trial was conducted across eight specialist clinics in the United Kingdom (UK) with 13 
assessments conducted in the clinic (trial sites) and interventions delivered in the home 14 
environment. A full description of the trial protocol can be found elsewhere15.  15 
 Participants were eligible if they 1) had a diagnosis of manifest HD, confirmed by 16 
genetic testing, 2) had self-reported or physician-reported difficulties with walking and/or 17 
balance (but still able to walk with minimal assistance), 3) were over 18 years old, and 4) had 18 
a stable medication regime for four weeks prior and were anticipated to maintain a stable 19 
regime for the duration. Participants were ineligible if they 1) had any physical or psychiatric 20 
condition that would prohibit the participant from completing the intervention or assessments, 21 
2) were unable to communicate in spoken English, or 3) were involved in (or were within 22 
four weeks of completing) any other interventional trial. Enroll-HD study is an observational 23 
cohort study providing a full clinical dataset, including full medical history and medication 24 




participants also give their permission for their coded data to be accessed by researchers 1 
conducting other HD-related research. Participants were either required to be on Enroll-HD 2 
or the relevant medical history and data provided through participation in Enroll-HD needed 3 
to be provided independently by the site. If this data were not able to be provided by the site, 4 
participants were considered ineligible. Ethical approval was obtained at all sites and 5 
participants provided informed consent.  A screening log was maintained at each site, 6 
recording numbers approached, eligible and declined.  7 
Randomisation and blinding 8 
Randomisation (ratio of 1:1) and automatic allocation was accomplished using a purpose 9 
developed web-based system16. Minimisation was used to achieve balance between groups 10 
based on data obtained at the baseline assessment17. Minimisation variables were: site of 11 
recruitment; age (< or >50 years old); gender; Unified Huntington’s Disease Rating Scale 12 
(UHDRS) Total Motor Score (TMS) (< or > 45). Independent outcome assessors were 13 
blinded to group allocation. Site staff inputted the minimisation variables and this generated 14 
an allocation from an algorithm developed by our database programmers. Neither the 15 
participants nor the intervention therapists were blinded.  16 
Interventions 17 
Physical Activity Intervention. The Engage-HD Physical Activity intervention was grounded 18 
within the framework of self-determination theory (SDT)18, and consisted of three main 19 
elements: the participant/coach interaction, the Engage-HD Workbook and an exercise DVD 20 
(Move to Exercise)4,19. A full description of the intervention in line with TIDieR guidelines 21 
for reporting interventions in trials20 are published elsewhere21 and summarised in Table 2 22 
(contact corresponding author for additional information). 23 
<Table 2> 24 
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Coaches conducted six home visits over 14 weeks (weeks 1, 2, 3, 6, 10 and 14) and three 1 
interim phone calls (weeks 4, 8 and 12) that served to provide encouragement in relation to 2 
regular physical activity. In partnership with their coaches, participants developed up to three 3 
realistic physical activity goals and were assisted with individual physical activity 4 
progression through goal discussion. Goal achievement was assessed by the coach at the last 5 
home visit. Exercise diaries and pedometers were provided to record the amount and type of 6 
physical activity involvement (e.g. walking or use of DVD and pedometers). Similarly, health 7 
and falls diaries facilitated documentation of falls, medication changes or contact with 8 
healthcare services.   9 
Social Interaction Intervention. The social intervention provided conversational interaction 10 
(see Table 2). This intervention was developed by our team in order to provide us with a 11 
comparator that could help to both control for contact time and account for the potential 12 
influence of the interpersonal skills (i.e. relatedness) of the coach on any treatment effect 13 
whilst not focussing particularly on the goal setting processes inherent in a physical activity 14 
self-management intervention. This approach to facilitate the understanding of individual 15 
components of interventions is in line with the UK Medical Research Council (MRC) 16 
framework for development and evaluation of complex interventions22. 17 
  Home visits were conducted at weeks 1, 2, 3, 6, 10 and 14 and supportive phone calls, 18 
at weeks 4, 8 and 12. At each visit, the social activity coach engaged the participant in a 19 
talking and communication interaction. Conversation cards (with images and text) 20 
representing a wide range of topics stimulated discussions (contact corresponding author for 21 
more information).  Health and falls diaries were completed but we did not ask those in the 22 
social intervention to keep exercise diaries.  23 
Coaches and training.  Coaches were either a) healthcare professionals (e.g. physical 24 
therapists, occupational therapists or nurses) with experience of delivering exercise related 25 
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activities or with specific experience with HD; or b) exercise professionals.  All staff had to 1 
meet specific health competencies. Nevertheless, across the sites, the coaches had a wide 2 
range of backgrounds and experiences, hence the need for centralized and standardized 3 
training and support.  This was provided by the chief investigator and the intervention 4 
coordinator, both of whom were research physical therapists with extensive experience 5 
working with the HD community in both clinical practice and research. All coaches attended 6 
a 1 day face-to face training day prior to the start of the trial at each site and were trained to 7 
deliver both the physical and social interventions according to structured protocols. In 8 
addition, physical activity coaches participated in a minimum of two phone/video 9 
conferences (per participant) with the intervention coordinator to discuss goal setting or any 10 
participant-specific concerns or issues.   11 
A coach’s manual provided a session-by-session guide, familiarized the coaches with 12 
the specific challenges of working with patients with HD, and offered a background to the 13 
intervention’s SDT framework. Full details of the visit schedules, training and coaching 14 
support are reported elsewhere21.   15 
Intervention fidelity. The multiple modalities of intervention delivery necessitated different 16 
fidelity measures.  Fidelity of the physical activity intervention was measured using a 17 
combination of self-report checklists, independent analysis of audio recordings and a self-18 
assessment completed by the intervention coaches. Full details of physical activity 19 
intervention fidelity (including the use of a purpose developed rating scale) are published 20 
elsewhere21. Social intervention fidelity was assessed as total time spent in the home during 21 
the visit and length of interim telephone calls. This was chosen to control for any confounds 22 
in relation to contact time. As a further evaluation, coaches were asked to record details of the 23 
conversations that we used to confirm the focus of discussions (and in particular to establish 24 
that the discussions were not related to physical activity).  25 
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Outcomes and Follow-up (see Table 1)  1 
Baseline measures included age, gender, height, weight, level of education, Social Support 2 
for Exercise survey and several disease-specific measures. The Social Support for Exercise 3 
survey23 assesses the level of support individuals feel they are receiving from family and 4 
friends while making health behavior changes. Disease specific measures (obtained from 5 
Enroll-HD or clinical records) included the Unified Huntington’s Disease Rating Scale 6 
(UHDRS) 24 Total Motor Score (TMS), which measures voluntary and involuntary motor 7 
impairments specific to HD, and Total Functional Capacity (TFC), which assesses capacity to 8 
work, handle finances, perform domestic chores and self-care tasks, and live independently.  9 
Functional Assessment and Independence Scale were also assessed. Medication at baseline 10 
(coded as analgesic, anti-choreic, anti-depressant, antihypertensive, diabetes and other) was 11 
also recorded.  12 
 We defined a-priori feasibility objectives based on our evaluation of eligibility 13 
(assessed through screening logs maintained at each research site) and recruitment and 14 
retention rates (monitored through a bespoke clinical trials database and evaluated based on 15 
the final number of participants successfully consented, randomised and retained)).  We also 16 
monitored completion of outcome measures, protocol deviations (using standard operating 17 
procedures as part of a formal quality management system inherent in a UK registered 18 
clinical trials unit) and documented both intervention fidelity and adherence to the 19 
intervention (measured using patient diaries) as well as safety (adverse event reporting 20 
documented in accordance with the governance requirements of safety reporting in a trial not 21 
involving an investigational medicinal product).  We agreed that a retention rate greater than 22 
the 75% would suggest that the intervention and trial processes were feasible. If the 23 
proportion retained was less than this but greater than 65%, we would consider adjusting the 24 
intervention. Adherence to both the physical and social intervention was considered sufficient 25 
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if at least 75% of the participants completed visit one, two and three with their activity coach 1 
(of a possible six visits). We set this threshold for adherence relative to the number of visits 2 
required to discuss all content of the physical activity workbook and to agree goals. The 3 
minimum threshold for adherence to exercise diary completion was defined as valid data 4 
reported for at least four days or more in over half the weeks during the intervention for any 5 
one of the components.   6 
 As recommended in the CONSORT extension for randomised pilot studies 14, reporting 7 
of effect size estimates and measures of uncertainty is critical to inform fully powered future 8 
evaluation. We therefore explored a range of potential outcomes in both groups. Function 9 
was assessed using the Physical Performance Test (PPT), an assessment incorporating a 10 
series of 9 primarily timed functional tasks that are converted to categorical variables (0-4) 11 
and summed to give a score between 0 (severe problems) and 36 (minimal problems)25. Self-12 
reported physical activity was measured using the International Physical Activity 13 
Questionnaire (IPAQ) – short form 26. Home and community mobility was reflected by the 14 
Life Space Assessment27. The Lorig scale provided a measure of self-efficacy28. Walking 15 
ability was assessed using the six minute walk test29, a measure of walking endurance that 16 
measures distance walked in 6 minutes, and the Timed up and Go Test30, which measures the 17 
time to stand up from a chair, walk 3 meters turn and walk back, and sit down. Participants 18 
completed the EQ-5D generic health capability measure31 and the ICECAP-A generic health 19 
measure via interview32. Self-reported frequency, circumstance and severity of any falls over 20 
the past four months was recorded at the baseline, primary end point assessments and over 21 
the past two months at follow up. The PAS Healthcare Climate Questionnaire (short form)33 22 
was used to assess participants’ perceptions of the degree to which their coach 23 
accommodated their individual needs, choices and perspectives. Motor function was assessed 24 
using the modified UHDRS Motor Score (mMS), a subset of items in the UHDRS TMS, 25 
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chosen due to its specific focus on voluntary motor impairments. Cognitive function was 1 
assessed using verbal fluency and symbol digit modality tests34, both of which have been 2 
shown to be sensitive to cognitive impairments in HD34.  3 
Statistical Analysis 4 
We planned to recruit 62 participants to estimate feasibility proportions for retention and 5 
adherence within 14 percentage points either side using a 95% confidence interval. This 6 
target allowed for 25% loss to follow up. Descriptive analyses (with 95% confidence 7 
intervals where relevant) included an evaluation of eligibility, recruitment, retention rates, 8 
completion of outcome measures and assessments. Diary usage was summarised by 9 
constituent components i.e. DVD use, pedometer use and reported walking time. Falls diary 10 
data were analysed using frequency analysis.  11 
 Both unadjusted and adjusted between group differences for outcome measures are 12 
presented. Adjusted estimates were calculated controlling for baseline measures of outcome 13 
scores (i.e. Analysis of Covariance (ANCOVA)) in addition to the balancing variables (age, 14 
gender and UHDRS motor score). This approach was taken in order to provide the most valid 15 
effect size estimates for this relatively rare study population35.   16 
Standard transformations were explored to improve model fit. All these analyses were on an 17 
intention to treat (ITT) basis although the primary analysis used the complete case data set.  18 
 The cost to deliver both the physical and social interventions was calculated by 19 
multiplying the hourly salary rate of the intervention staff (including salary on costs) by the 20 
time taken to arrange, travel to and conduct sessions; mileage costs were based on a 21 
reimbursement rate of £0.40 per mile. Journey time and mileage was calculated as the round 22 
trip (e.g. a 12 minute journey to visit the participant is recorded as 24 minutes of staff time).  23 
Role of the funding source: The funders had no involvement in the conduct of this pilot 24 




Feasibility  2 
Participants were recruited between 23 June 2014 and 21 August 2015. There was variability 3 
in screening processes at sites with some sites screening large numbers of potential 4 
participants, of whom a small fraction were eligible, and an even smaller fraction were 5 
recruited. Others screened only eligible participants and recruited over three quarters of those 6 
screened (see Table 3 for a summary of screening, enrolment and recruitment information 7 
according to site).  8 
 One hundred and fifteen (46%) out of 249 HD patients screened were eligible (with 9 
many of these excluded based on the recruiting clinician’s impression that they had a physical 10 
or psychiatric condition that would prevent them from completing the intervention); 46 (40%) 11 
were enrolled, 22 randomised to the physical intervention and 24 to the social intervention.  12 
Only 2 of the trial sites recruited to time and target, although we did recruit 46 participants 13 
(74% of the target). It was necessary to extend the time period for recruitment by 2 months 14 
and furthermore to implement active site monitoring in some situations where recruitment 15 
was particularly slow. The main reasons for sites struggling to recruit were related to either 16 
competing drug trials (in 4 of the sites) or to research staff maternity and/or long term illness 17 
(in 2 of the sites). Of the 138 participants that were deemed ineligible 62 of these (45%) were 18 
excluded on the grounds that they had a ‘physical or psychiatric condition that would prohibit 19 
the participant from completing the intervention or assessments’. This included people with 20 
advanced chorea and those known not to engage with healthcare services. Baseline 21 
characteristics were similar between groups (see Table 4 and Figure 1).  22 
<Table 3 here> 23 
<Figure 1> 24 
<Table 4> 25 
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 There were three full withdrawals in the physical activity group (felt unable/ did not 1 
want to complete intervention (n=2); change in home circumstances and illness (n=1)) with 2 
one withdrawal from the intervention only (due to illness), and two losses to follow up in the 3 
physical group (death (n=1); prolonged hospitalisation (n=1)) prior to the primary endpoint 4 
(see Figure 1). Two participants in the social contact group missed the primary end point 5 
assessment, but did complete the follow up assessment. This resulted in a retention rate of 6 
77% (95% CI: 54-91%) in the physical activity group and 92% (72-99%) in the social contact 7 
group.  8 
Intervention fidelity and adherence 9 
Mean (SD) interaction time spent in the home for the physical activity intervention across all 10 
visits was 58.3 (8.9) minutes. Mean (SD) time spent in discussion across telephone calls was 11 
10.1 (6.7) minutes. Mean (SD) interaction time spent in the home for the social intervention 12 
across all visits was 50.7 (2.7) minutes. Mean (SD) time spent in discussion across telephone 13 
calls was 10.7 (6.7) minutes. Median (range) number of physical activity intervention visits 14 
completed were 6 (0-6) and social activity intervention visits were 6 (3-6). In the physical 15 
intervention arm, 82% of participants completed visits one, two and three and 68% completed 16 
all scheduled visits; 100% of participants in the social intervention completed visits one, two 17 
and three and 88% completed all visits.   18 
 Exercise diary data was available for 17/22 participants at the primary endpoint (only 19 
those in the physical intervention completed the exercise diaries). Thirteen (76%) participants 20 
adhered to at least one component of the intervention for a minimum of seven weeks during 21 
the course of the intervention. Forty-six % of participants recorded walking time, 51% 22 
recorded pedometer readings and 70% recorded using the DVD. The average daily time spent 23 
using the DVD over 13 weeks was 16.4 (SD 3.0) minutes, the average daily time spent 24 
walking was 63 minutes (SD 14.5) with average daily pedometer count 6,254 steps (SD 998). 25 
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Participant goals (Physical Intervention only) 1 
Up to three goals were recorded by the end of visit 3 for the 19 participants in the physical 2 
activity group. In total, 50 goals were recorded for 19 participants; 19 of these were related to 3 
walking, 21 to structured exercise, 6 to increasing general activity, 2 to reducing sitting time 4 
and 2 were sports and recreational activity based. Of the 19 participants that recorded goals at 5 
the start of the intervention, 3 participants (1 who had made three goals and 2 who had made 6 
two goals) did not complete the intervention. Sixty-seven % of goals were achieved at the 7 
expected outcome or better with the majority of these being related to general activity goals 8 
and walking goals.  9 
 10 
Outcomes 11 
Table 5 summarises the baseline and follow-up scores of key outcome variables, as well as 12 
presenting unadjusted and adjusted between group differences. Both unadjusted and adjusted 13 
differences indicate potential treatment effects for the IPAQ, Life Space, self-efficacy for 14 
exercise and symbol digit modality test, which should be explored in future confirmatory 15 
trials.  16 
<Table 5> 17 
Falls 18 
 During the intervention period, 16 physical activity group participants used falls diaries 19 
regularly and 14 falls were reported; 23 social activity intervention group participants used 20 
diaries regularly and 24 falls were reported.  21 
Adverse events 22 
In total, seven adverse and three serious adverse events (two intervention; death (n=1) & 23 
prolonged hospitalisation due to deterioration in mental health status (n=1), one social; 24 
hospitalisation due to deterioration in mental health status) were reported during the trial); 25 
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none were related to the intervention and were primarily as a result of concurrent illnesses. 1 
Two of the adverse events involved falls; one from falling on ice and one from tripping on 2 
the stairs, both of which required medical attention but not hospital admission (one physical 3 
intervention, one social arm). 4 
Cost of Physical Intervention Delivery 5 
Our economic analysis used 2014/15 as a cost year, and a public sector perspective of 6 
analysis. One-hundred-and-five home visits were delivered at a total cost of £5,982 (mean 7 
cost per session £56.97, SD £34.72). This equates to a cost £341.82 per participant. Mean 8 
contact time for participants in the physical intervention arm was 57.7 minutes per home 9 
session. Telephone calls cost an additional £2.77 per contact.  In total, 22.8 hours (1370 10 
minutes) were spent discussing the physical intervention with the lead intervention 11 
coordinator. The per participant cost of lead intervention supervision was £52.97. The costs 12 
to develop the intervention and the cost associated with training staff to deliver the 13 
intervention have been reported previously21. 14 
Cost of Social Intervention Delivery 15 
For the social intervention, participants received one-hundred-and-thirty-nine visits, delivered 16 
at a total cost of £5387 (mean cost per session £38.76, SD £20.05). Mean contact time for 17 
participants in the social intervention was of 50.6 minutes per home session. Telephone calls 18 
cost an additional £2.79 per contact. Supervision time with the lead intervention coordinator 19 
for the social intervention was minimal (£3.03 per participant). 20 
 21 
Discussion 22 
This trial has helped to establish feasibility and explore adherence and outcomes in relation to 23 
a purpose-developed physical activity behavior change intervention for people with HD in 24 
comparison to a social contact comparator.  We have shown that it is possible to recruit 25 
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participants to this study and through the robust intervention description and development of 1 
comprehensive training and monitoring of associated fidelity we have clear indications of 2 
how to support the delivery of such a trial. The dropout rate was lower in the social 3 
intervention than physical intervention. Trial discontinuation records suggest that those 4 
participants withdrawing from the physical intervention were faced with a variety of 5 
unrelated life challenges and reported difficulty in complying with the requirements of the 6 
physical activity intervention. This highlights the importance of considering the personal 7 
challenges experienced by those living with a neurodegenerative disease so that therapists are 8 
able to identify when individuals may benefit from extra support to sustain physical activity. 9 
This trial was conducted across 6 specialist centres in the UK covering both rural and urban 10 
areas. The intervention was highly manualised, included expert oversight from a lead 11 
intervention therapist and preliminary cost analyses that altogether provides excellent 12 
evidence for designing future definitive trials in a UK setting. 13 
 Critical to our intervention development was acknowledgement of the complex array of 14 
cognitive, behavioral and motor symptoms that can lead to highly risky sedentary behaviors 15 
in HD36.  Our intervention approach included one-to-one coaching and telephone support and 16 
a coaching style that highlighted autonomy, competence and relatedness as well as 17 
considering disease specific barriers (in this case cognitive limitations and apathy, a common 18 
behavioral problem in HD) and wider environmental and social aspects. To our knowledge, 19 
this is the first implementation of a social contact comparator in a physical activity 20 
intervention trial targeting a neurological population; thus the observable between-group 21 
differences in physical activity provides some initial suggestion that the coaching approach 22 
was indeed linked to physical activity outcomes rather than benefit incurred through social 23 
contact. The relative increase in self-efficacy for exercise along with increased levels of 24 
physical activity as a result of the coaching intervention despite the complexity of 25 
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impairments in HD reinforces the importance of specific support for exercise in complex and 1 
chronic conditions such as HD and is therefore a target for future confirmatory studies. It also 2 
lends supports to our pre-defined logic model and gives us some confidence that the observed 3 
outcomes, namely improved lifespace and self-efficacy could be related to the intervention 4 
inputs. However, it is likely that a critical factor to achieving functional benefit is exercise 5 
adherence over a longer duration. 6 
 We must acknowledge the limitations inherent in this pilot feasibility trial. The large 7 
number of outcome measures may have been unduly burdensome for sites and participants, 8 
but we are now in a position to define a more focussed assessment battery in a definitive trial. 9 
Additionally, the self-report measures utilized, such as the IPAQ, may have introduced bias.  10 
Employing more intuitive monitoring approaches, e.g. wearable technologies to 11 
quantitatively measure physical activity37, may be helpful. This study also did not assess any 12 
carer impact as result of the person with HD participating in this trial. Future trials may want 13 
to consider recruiting carer-companions or HD family dyads not only to optimise recruitment 14 
and retention but also to facilitate wider physical activity related health benefits38. 15 
  Defining and developing methods to facilitate physical activity behavior change is of 16 
great interest to neurologic physical therapy practice. This may in part be due to the greater 17 
acknowledgement of the critical role for physical activity as a potential disease modifying 18 
intervention39,40, but more likely the urgent need for implementing secondary preventive 19 
strategies for the large numbers of individuals living with a chronic diseases41. There is an 20 
increasing focus on the development and evaluation of theory-driven approaches embedded 21 
in specifically tailored programs to achieve sustained behaviour change for people with 22 
neurodegenerative and neuro-inflammatory diseases such as Parkinson’s Disease (PD) and 23 
Multiple Sclerosis (MS)42–48. Here we report the first such pilot feasibility trial in HD,  a well 24 
characterized single gene neurodegenerative disorder that is an excellent model that can be 25 
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easily adapted to individuals with dementias and movement disorders more generally49, as 1 
well as for individuals with rare neurodegenerative diseases. Supporting ongoing physical 2 
activity in an environment of changing physical and cognitive function has the potential to 3 
enhance meaningful participation in usual life activities and could lead to important public 4 
health benefits for these populations. Given the success achieved (with relatively low cost) in 5 
this highly challenging and complex condition, we suggest that this approach has wider 6 
applicability and should be subject to a full scale efficacy evaluation in HD over a longer 7 
duration and is worthy of exploration in a broad range of neurodegenerative conditions where 8 
cognition, behaviour and apathy limit ongoing physical activity engagement. 9 
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Table 1: Schedule of enrolment, interventions, and assessments 
STUDY PERIOD 
 Enrolment Allocation Post-allocation Follow-up 
TIMEPOINT** - 4 wks 0 0 2 wks 3 wks 4 wks 6 wks 8 wks. 10 wks 12 wks 14 wks 15 wks 16 wks 26 wks 
ENROLMENT               




           
Eligibility screen  X             
Informed consent   X             
Registration   X             
Physical Activity Readiness 




           





           
Physical intervention visits     X X X  X  X  X   




  X         
Physical Intervention Group: 




 X X  X  X  X   
Physical Intervention Group: 
Review Exercise diaries 
  
 
   X  X  X    




   X  X  X    
SOCIAL INTERVENTION:               
Social intervention visits    X X X  X  X  X   
Social Intervention Group: 




 X X  X  X  X   




   X  X  X    
ASSESSMENTS:  X           X X 
Medication at baseline  X 
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Social Support for Exercise  X 
            
UHDRS total motor scale, 




           
Physical Performance Test 
 X 
 






        X  X 
LifeSpace Assessment  X 
         X  X 
Lorig Self-Efficacy Scale  X 
          X X 
Self-reported Falls  X 
          X X 




         X X 
Six minute walk test  X 
          X X 
Timed Up and Go Test  X 
          X X 
EQ-5D  X 
          X X 
ICECAP-A  X 
          X X 
Symbol digit modality test  X 
          X X 
Verbal Category Fluency  X 
          X X 











Table 2: Intervention Details described in line with the TIDIER framework for intervention description 
 
     
1 NAME Provide the name or a 
phrase that describes 
the intervention 
Engage-HD Physical Activity intervention Engage-HD Social Interaction Intervention 
2 WHY Describe any rationale, 
theory, or goal of the 
elements essential to 
the intervention 
The Engage-HD Physical Activity intervention specifically 
focused on developing an individualized lifestyle approach to 
enhancing physical activity with interpersonal interactions of 
the physical activity coach underpinned by the concepts of 
self-determination theory (SDT). 
The function of the additional intervention components, 
namely a physical activity workbook and exercise DVD, were 
to facilitate education, enablement, modelling and goal 
setting.  
The Engage-HD Social Interaction Intervention was a 
comparator intervention that provided conversational 
interaction. This social intervention was developed by 
our team in order to provide us with a comparator that 
could help us to both control for contact time and 
account for the potential influence of the interpersonal 
skills (i.e. relatedness) of the coach on any treatment 
effect while not focussing particularly on the goal setting 
processes inherent in a physical activity self-
management intervention. 
 
3 WHAT Materials: Describe any 
physical or 
informational materials 
used in the intervention, 
including those 
provided to participants 
or used in intervention 
delivery or in training 
of intervention 
providers. Provide 
information on where 
the materials can be 
accessed (e.g. online 
appendix, URL). 
This complex intervention consisted of 3 main elements, 
namely the Participant/coach interaction (underpinned by 
SDT), a purpose developed ENGAGE-HD Workbook.  The 
Workbook focused on disease specific information to facilitate 
exercise uptake, instructions on use of pedometers, and a goal 
setting section. 
The exercise DVD (Move to Exercise) can be accessed online 
at: https://www.youtube.com/watch?v=6P-
o4a6ht7Q&list=PLOi2wccX7y-
YEC2Ww3IRiBbgAQ7YJmaSm; (accessed 18/01/2017). 
 
Conversation cards (with images and text) representing a 
wide range of topics were used to help direct 
conversation toward topics of potential interest to the 
participants during each visit. In the first session, a 
‘getting to know you’ conversation took place. Further 
discussions could focus on a range of topics including 
travel, media, food, music and art, entertainment, 
shopping, animals, science, technology, friends and 
socializing.  
4 Procedures: Describe 
each of the procedures, 
activities, and/or 
processes used in the 
intervention, including 
Participants enrolled in the ENGAGE-HD physical activity 
intervention received six home visits and interim telephone 
calls over a course of 14 weeks, during which time they were 
supported by trained activity coaches to develop an 
individualized, lifestyle approach to enhancing physical 
activity.  
Participants enrolled in the ENGAGE-HD social 
interaction intervention received six home visits and 
interim telephone calls over a course of 14 weeks.  
 
At each face-to-face visit, the coach engaged with the 
participant in a talking and communication interaction 
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any enabling or support 
activities. 
 
During the first face-to-face visit, the coach introduced the 
participant to the ENGAGE-HD physical activity 
intervention, the workbook and the exercise diaries, which 
participants were asked to complete each week. The initial 
interactions considered benefits of physical activity and each 
participant’s individual exercise history, as well as setting 
specific physical activity goals. Further discussion topics on 
physical activity included implementing a daily activity plan, 
monitoring exercise intensity, dealing with safety, weather, 
equipment and typical barriers (such as time, boredom, lack of 
equipment, lack of specific knowledge and support). In the 
remaining five home sessions, the coach continued to support 
discussions related to the activities in the workbook, and 
supervised the participant performing components of the 
Move to Exercise DVD exercise program or other physical 
activities. Coaches also reviewed exercise diaries completed 
during the previous week(s). 
 
Supportive telephone calls were conducted three times over 
the 14- week-period. These calls served to provide 
encouragement and advice with respect to the promotion of 
regular physical activity. During the calls, the coach also 
asked about any falls, health or medication changes and 
confirm the date and time of the next visit.  
using purpose developed conversation cards (with 
images and text) representing a wide range of topics to 
help direct conversation toward topics of potential 
interest to the participants during each visit. 
 
Reminder telephone calls were conducted three times 
over the 14-week-period. These calls will served to 
match the contact time provided to the physical 
intervention group. During the calls, the coach asked 
about any falls, health or medication changes and 
confirmed the date and time of the next visit. 
 
At each home visit, the coach also completed a health 
and falls review with the participant where they will 
asked about (and recorded any details of) any falls, 








describe their expertise, 
background and any 
specific training given.  
Intervention delivery coaches were trained at a total of 8 sites. 
The coaches delivering the ENGAGE-HD physical activity 
interventions were either (a) health care professionals (e.g., 
Physical therapists (n=3), Occupational therapists, or Nurses 
(n=4)) with experience of delivering exercise-related activities 
or with specific experience with HD; or (b) exercise 
professionals (n=2). All staff had to meet specific health 
competencies, namely Skills for Life Competencies, 
developed by the National Health System (NHS) in the UK. 
(Competencies can be found at Skills for 




Intervention delivery coaches were trained at a total of 8 
sites. The coaches delivering the ENGAGE-HD social 
interaction interventions were either (a) health care 
professionals (e.g. Occupational therapists (n=1), Nurses 
(n=7),) support workers with experience of delivering 
exercise-related activities (n=1), researchers with 
specific experience with HD (n=1); or (b) exercise 
professionals (n=2). 
The training model was for a team, including the 
intervention coordinator, trial chief investigator, and trial 
manager to travel to the site location and conduct a 6-
hour training session in a small group setting. Coaches at 
sites received training in both interventions during this 6 
hour session.  
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The training model was for a team, including the intervention 
coordinator, trial chief investigator, and trial manager to travel 
to the site location and conduct a 6-hour training session in a 
small group setting. Coaches at sites received training in both 
interventions during this 6 hour session.  
 
Training for the physical coaches included a 1.5-hour, one-to-
one session with either the chief investigator or the 
intervention coordinator. Both the chief investigator and the 
intervention coordinator were research physical therapists 
with extensive experience working with the HD community in 
both clinical practice and research, who oversaw development 
of the training materials and ongoing support of the coaching 
staff. A coach’s manual was provided to each coach, and was 
used as a guide for each of the training sessions.  The manual 
gave an explicit, session-by-session guide, familiarized the 
coaches with the specific challenges of working with patients 
with HD, and offered a background to the intervention’s SDT 
framework. 
 
In addition to the initial training sessions and coaching 
manuals, coaches received ongoing support from the 
intervention coordinator. This support was particularly 
important in helping to guide coaches who have had little or 
no experience of working with patients with this relatively 
rare disease. Before each coach visited a participant for the 
first time, they were able to have a discussion with the 
intervention coordinator to assist them to interpret a 
participant’s baseline assessment scores. This allowed them to 
appropriately anticipate the ability level and potential needs of 
each participant. After the initial home visits, coaches had a 
further discussion with the intervention coordinator to 
develop realistic goals for the participants, based on each 
participant’s particular interests and their current ability 
levels. Coaches were further encouraged to contact the 
intervention coordinator if they had any questions about the 
home visits as the intervention progresses, either by e-mail or 
video-conferencing. 
 
Training for the social coaches also included a 1.5-hour, 
one to-one training with the lead intervention 
coordinator prior to the start of the trial at each site, and 
the intervention coordinator was available for 
consultation throughout the trial. 
 
A coach’s manual was provided to each coach, and was 
used as a guide for each of the training sessions.  The 
coaching manual gave an explicit, session-by-session 
guide and familiarized the coaches with the specific 
challenges of working with patients with HD, 
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6 HOW Describe the modes of 
delivery (e.g. face-to-
face or by some other 
mechanism, such as 
internet or telephone) of 
the intervention and 
whether it was provided 
individually or in a 
group. 
The physical activity sessions were delivered face-to-face. 
Supportive telephone calls were conducted three times over 
the 14- week-period. 
The social interaction sessions were delivered face-to-
face. Reminder telephone calls were conducted three 
times over the 14- week-period. 
7 WHERE Describe the type(s) of 
location(s) where the 
intervention occurred, 
including any necessary 
infrastructure or 
relevant features 
The physical activity sessions were delivered in each 
participant’s home.   
The social interaction sessions were delivered in each 
participant’s home.   
8 WHEN AND 
HOW MUCH 
Describe the number of 
times the intervention 
was delivered and over 
what period of time 
including the number of 
sessions, their schedule, 
and their duration, 
intensity or dose. 
Participants received six home visits and 3 interim telephone 
calls over a course of 14 weeks. Mean face-to-face session 
duration was 58.3 (8.9) minutes. Mean duration of telephone 
calls was 10.1 (6.7) minutes. 
Participants received six home visits and 3 interim 
telephone calls over a course of 14 weeks. Mean face-to-
face session duration was 50.7 (2.7) minutes. Mean 
duration of telephone calls was 10.7 (6.7) minutes. 
9 TAILORING If the intervention was 
planned to be 
personalised, titrated or 
adapted, then describe 
what, why, when, and 
how. 
The intervention was designed to be personalized to each 
individual by way of specific goal setting. Coaches worked 
together with participants to address individual barriers and 
facilitators to meeting goals. Goals were reviewed each 
session and the participant and coach worked collaboratively 
towards meeting the goals.  Coaches also provided 
individualized advice regarding progression of exercise and 
physical activity. 
There was no specific tailoring planned for the social 
interaction intervention.   
10 MODIFICAT
IONS 
If the intervention was 
modified during the 
course of the study, 
describe the changes 
(what, why, when, and 
how). 
The intervention was not modified during the course of the 
study.  




11 HOW WELL Planned: If intervention 
adherence or fidelity 
was assessed, describe 
how and by whom, and 
if any strategies were 
used 
Fidelity was measured by a combination of self-report 
checklists, independent assessment of the quality of the 
coaching sessions, based on audio recordings of the 3rd coach 
home visits. The fidelity of the coach interactions was 
measured by assessing the extent to which each coach 
demonstrated efforts to promote autonomy, relatedness, and 
competence, and a self-assessment completed by the 
intervention coaches. A set of 10 questions with a mix of 
rating scales (directly comparable to those scores used to rate 
fidelity) and free text answers were developed and delivered 
to the coaches via a web-based survey. The questions covered 
each coach’s views on the training provided, adherence of the 
intervention to SDT, accompanying materials used in the 
delivery of the intervention, and the intervention in general. 
Respondents were asked to identify themselves so that their 
answers could be linked to individual fidelity scores. 
Social intervention fidelity was assessed as total time 
spent in the home during the visit and length of interim 
telephone calls. This was chosen as the fidelity measure 
as we were looking to control for any confounds in 
relation to contact time. As a further evaluation, coaches 
were asked to record details of the conversations that we 
used to confirm the focus of discussions (and in 
particular to establish that the discussions were not 
related to physical activity).  
 
12 Actual: If intervention 
adherence or fidelity 
was assessed, describe 
the extent to which the 
intervention was 
delivered as planned. 
Mean (SD) interaction time spent in the home for the physical 
activity intervention across all visits was 58.3 (8.9) minutes. 
Mean (SD) time spent in discussion across telephone calls 
was 10.1 (6.7) minutes. Median (range) number of physical 
activity intervention visits completed were 6 (0-6). 
 
The self-report checklists completed by each of the coaches at 
the first home visit indicated that in 100% of sessions (16/16), 
coaches introduced the participants to the Physical Activity 
Workbook, gave the participants the exercise DVD and 
discussed the concept of goal-setting with the participant in 
100% of the sessions. Sessions lasted on average 72.3 
minutes. Fidelity scores for coach interactions, based on audio 
transcripts of the third intervention session, were assessed for 
15 of the 16 participants. Overall scores ranged from 7 to 14 
out of a possible 16 points, with a mean (standard deviation) 
score across the coaches of 11.0 (2.4). Coach interactions 
scored an average of 2.5/4 for autonomy, 3.0/4 for 
relatedness, 2.7/4 for competence, and 2.8/4 for the overall 
impression. Self-assessment scores were on average higher 
than those assigned by the independent rater, namely 3.1/4 for 
autonomy, 3.3/4 for relatedness, and 3.0/4 for competence. 
Mean (SD) interaction time spent in the home for the 
social intervention across all visits was 50.7 (2.7) 
minutes. Mean (SD) time spent in discussion across 
telephone calls was 10.7 (6.7) minutes. Median (range) 






Table 3: Screening vs Recruitment by individual site 




Screened   
(n) 











% of eligible 
actually 
recruited 













of time needed 







A 19 68 30 44 5 3 2 7 17 27 305 356 71.2 
B‡ 114 12 11 92 2 0 2 17 18 176 308 463 231.5 
C‡*∞ 52 19 4 21 4 2 2 21 100 49 301 309 77.3 
D‡ 269 9 6 67 6 3 3 67 100 61 392 392 65.3 
E*∞ 27 13 13 100 10 6 4 77 77 34 246 246 24.6 
F∞ 41 23 22 96 10 5 5 44 46 34 376 376 37.6 
G∞ 21 33 15 46 4 1 3 12 27 29 379 429 107.3 
H* 146 72 14 19 5 2 3 7 36 66 251 336 67.2 
 
1Registration as an Enroll-HD participant was a requirement unless the site could provide the medical history from clinical records. This number does not necessarily reflect 
the total number of HD patients serviced by the site but gives a good indication of the research active population at the site.   
‡ Centres concurrently hosting major drug trials 
* Centres with a physical therapist resident in clinic/ recruiting 






Table 4: Baseline demographics and clinical characteristics split by treatment arm  
Baseline demographics and clinical 
characteristics 
Physical Intervention Mean 
(SD) or count (%) 
Social Control  
Mean (SD) or count (%) 
Overall 
Age (years) 56.1 (10.3) 53.7 (9.9) 54.9 (10.1) 
Gender (Male; Female) 12 (54.5%); 10 (45.5%) † 13 (54.2%); 11 (45.8%) † 25 (54.3%); 21 (45.7%) † 
Height (m) 1.7 (0.1) 1.7 (0.1) 1.7(0.1) 
Weight (kilograms) 77.3 (18.5) 73.8 (14.7) 75.5 (16.5) 
Level of education 
CSE/GCE/GCSE school leaving 
certificate 
9 (40.9) † 3 (12.5) † 12 (26.1) † 
NVQ qualification 2 (9.1) † 5 (20.8) † 7 (15.2) † 
A Level 1 (4.5) † 3 (12.5) † 4 (8.7) † 
University degree 2 (9.1) † 4 (16.7) † 6 (13) † 
Other  8 (36.4) † 9 (37.5†) 17 (37) † 
Medication category    
Analgesic 3 6 
37 
 
Antichoreic 12 8  
Antidepressant 19 19 
Antihypertensive 7 7 
Diabetes 0 3 
Other 25 25 
Functional score (maximum 
score=25) 
16 (5) 18 (5) 17 (5) 
Social Support – friends  
(maximum score=60) 
15.0 (8.2) 17.0 (8.4) 16.1 (8.3) 
Social Support – family (maximum 
score=60) 




Table 5: Adjusted and unadjusted summaries of outcome measures at baseline, primary outcome assessment and follow-ups 




95% CI for the 
Difference.  
Adjusted 





Social Physical Intervention Social    
Physical Performance Test 
(PPT) 
24.6 (6.5) (n=22) 24.9 (4.3) (n=24) 25.8 (5.6) (n=16) 25.0 (4.8) (n=22) 0.8  -2.8,4.3 -2.1 to 2.7 
International Physical Activity 









1358.3 -521.2,3237.8 -22% to 
653%# 





Exercise 6.4 (2.9) (n=22) 7.3 (2.5) (n=24) 7.6 (2.1) (n=17) 6.5 (2.7) (n=22) 1.1 -0.4,2.7 0.6 to 2.7 
Information 7.5 (3.2) (n=22) 8.1 (2.5) (n=24) 8.2 (2.2) (n=17) 8.1 (2.7) (n=22) 0.1 -1.4, 1.7 -1.3 to 1.6 
Help 7.4 (2.1) (n=22) 8.2 (1.6) (n=24) 8.0 (2.1) (n=17) 7.7 (1.7) (n=22) 0.3 -1.0, 1.5 -1.0 to 1.4 
Communication 8.4 (1.9) (n=22) 8.9 (1.4) (n=24) 8.8 (1.2) (n=17) 8.5 (1.7) (n=22) 0.2 -0.7,1.2 -0.4 to 1.2 
Manage disease 7.0 (2.5) (n=22) 7.2 (2.2) (n=24) 7.8 (1.7) (n=17) 7.0 (2.1) (n=22) 0.8 -0.5,2.0 -0.6 to 1.2 
Do chores 6.7 (2.7) (n=22) 6.5 (3.5) (n=24) 7.0 (2.6) (n=17) 7.1 (2.2) (n=22) -0.1 -1.7, 1.5 -1.9 to 0.8 
Social 6.7 (3.1) (n=22) 7.1 (3.3) (n=23) 7.1 (2.8) (n=17) 7.0 (2.8) (n=22) 0.2 -1.6,2.0 -1.4 to 1.8 
Manage symptoms 6.5 (2.7) (n=21) 6.9 (2.5) (n=22) 7.3 (2.3) (n=16) 6.8 (2.6) (n=22) 0.5 -1.1,2.1 -1.0 to 1.6 
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SOB 7.8 (2.3) (n=20) 8.2 (2.6) (n=20) 8.8 (1.6) (n=15) 7.7 (3.1) (n=19) 1.1 -0.6,2.8 -0.01 to 2.8 
Manage depression 6.9 (3.0) (n=22) 7.0 (2.6) (n=24) 7.6 (2.3) (n=17) 7.3 (2.3) (n=22) 0.3 -1.2,1.8 -1.2 to 0.6 
UHDRS modified motor 
assessment 
18.1 (7.4) (n=22) 17.2 (6.7) (n=24) 17.9 (6.4) (n=16)  17.6 (6.6) (n=23) 0.3 -4.0, 4.6 -2.1 to 3.4 




352.5 (103.2) (n=17) 334.8 (156.3) (n=23) 17.7 -65.5, 100.9 -20 to 109 
Timed Up and Go Test (TUG) 
(seconds) 
13.5 (8.9)(n=21) 11.1 (3.2) (n=24) 10.6 (2.0) (n=16) 11.2 (3.0) (n=23) -0.5 -2.1,1.1 -2.6 to 0.3 
EQ5D 0.7 (0.2) (n=22) 0.6 (0.3) (n=24) 0.7 (0.2) (n=17) 0.7 (0.3) (n=23) 0.1 -0.1,0.2 -0.12 to 0.11 
ICECAP 0.8 (0.2) (n=22) 0.8 (0.2) (n=24) 0.9 (0.1) (n=17) 0.8 (0.1) (n=23) 0.0 -0.1,0.1 -0.06 to 0.03 
Symbol digit modality test 
(correct) 
18.3 (7.9) (n=22) 24.0 (8.9) (n=24) 21.6 (6.1) (n=17) 23.3 (10.7) (n=23) -1.7 -7.1,3.8 0.01 to 5.9 
Category Fluency 10.5 (3.7) (n=22) 12.4 (4.6) (n=24) 11.9 (4.4) (n=17) 12.0 (5.0) (n=23) -0.1 -3.1,3.0 -1.3 to 2.7 
PAS healthcare climate - - 6.0 (1.3) (n=17) 6.3 (1.1) (n=22) -0.3 -1.1,0.4 - 
* Physical – Social  
†95% CI is adjusted for baseline Physical Performance Test (PPT), treatment arm, and all minimisation variables (age (less than 50/greater than or equal to 50), sex, Unified 
Huntington’s Disease Rating Scale (UHDRS) total motor score (less than 45/greater than or equal to 45), site (Staffordshire, Birmingham, Manchester, Sheffield, 
Southampton, Aberdeen, Bristol, Cardiff)) 






Figure 1: CONSORT Flow Chart 
 
 
 
 
